Open AccessMycophenolate mofetil‐induced peripheral neuropathy in the treatment of membranous glomerulonephropathy: A case report
Author(s) -
Moghimi Minoo,
Nekoukar Zahra,
Gholami Farhad
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.5161
Subject(s) - mycophenolate , medicine , peripheral neuropathy , peripheral , polyneuropathy , dermatology , pathology , surgery , transplantation , diabetes mellitus , endocrinology
Mycophenolate mofetil (MMF) as an immunosuppressive agent is widely used in the management of Membranous Glomerulonephropathy (MGN). In this report, we described a 66‐year‐old male MGN case treated with MMF and revealed acquired sensory‐motor axonal polyneuropathy, which is rare and has not been reported before.